Call 408.493.1800 | Fax 408.493.1801 | Toll Free 800.891.9699 (US Only) | Email: [email protected]

Anti-IL-17α, Humanized Antibody (Ix3)

Biosimilar to Ixekizumab, monoclonal antibody that targets IL-17α
Catalog #: A2149
$455.00

Product Details

Cat # +Size A2149-100
Size 100 μg
Antibody Target IL-17α
Alternate Name IL17a, IL17, CTLA8, IL-17, CTLA-8, IL-17A
Host Recombinant
Antibody Type Monoclonal
Isotype IgG4, kappa
Immunogen Human IL-17α
Accession # DB11569
Appearance Colorless liquid
Formulation In PBS, pH 7.5
Species Reactivity Human
Handling The antibody solution should be gently mixed before use.
Storage Conditions -80°C
Shipping Conditions Gel Pack
USAGE For Research Use Only! Not For Use in Humans.

Details

The research-grade biosimilar is a humanized IgG4 monoclonal antibody that targets IL-17α. IL-17α is a proinflammatory cytokine produced by activated T cells. Downstream responses include the production of inflammatory molecules, chemokines, antimicrobial peptides, and remodeling proteins. IL-17α is involved in host defense, cell trafficking, immune modulation, and tissue repair, and is known to play an important role in autoimmune diseases such as rheumatoid arthritis and plaque psoriasis.


Why buy BioVision Products?
Innovation
Affordability
Global Presence
Technical Support
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways.
BioVision is committed to providing the highest quality products at a competitive price.
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery.
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently.